| 前收市價 | 89.78 |
| 開市 | 88.26 |
| 買盤 | 0.00 x 0 |
| 賣出價 | 0.00 x 0 |
| 今日波幅 | 90.00 - 90.74 |
| 52 週波幅 | 79.21 - 94.52 |
| 成交量 | |
| 平均成交量 | 3,212,827 |
| 市值 | 184.739B |
| Beta 值 (5 年，每月) | 0.47 |
| 市盈率 (最近 12 個月) | 22.69 |
| 每股盈利 (最近 12 個月) | 3.99 |
| 業績公佈日 | 2024年7月18日 |
| 遠期股息及收益率 | 3.30 (3.64%) |
| 除息日 | 2024年3月07日 |
| 1 年預測目標價 | 86.92 |
Motley Fool2 Magnificent Dividend Stocks to Hold for the Next Decade
The dividend is just one reason to buy these stocks.
ZacksAlnylam (ALNY) Q1 Loss Narrower Than Expected, Sales Rise Y/Y
Alnylam (ALNY) reports better-than-expected first-quarter 2024 results as both earnings and revenues beat estimates, primarily driven by strong Amvuttra sales.
- Reuters
UPDATE 2-Novartis to buy radiology drug specialist Mariana for $1 billion
Novartis agreed to acquire U.S. radiopharmaceutical company Mariana Oncology for $1 billion upfront, boosting its portfolio of precision cancer treatments in development, the Swiss drug manufacturer said on Thursday. Mariana Oncology is working on novel radioligand cancer therapies (RLTs) that have not yet been tested on humans. "The transaction bolsters the Novartis RLT pipeline and expands the company’s research infrastructure and clinical supply capabilities," Novartis said in a statement.
